Comoli P, Basso S, Huanga GC. Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita: report of a case. Int J Hematol. 2005;82:35–37. Article Google Scholar Drachtman RA, Alter BP. Dyskeratosis congenita: Clinical and genetic heterogeneity. Report of a new case and review of the literature. Am J Pediatr Hematol Oncol. 1992;14:297–304. Article CAS Google Scholar Marrone A, Dokal I. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer. Expert Rev Mol Med. 2004;6:1–23. Article Google Scholar Alter BP, Baerlocher G, Savage S, et al. Diagnosis of dyskeratosis congenita by telomere length. Pediatr Blood Cancer. 2005;44:537. Google Scholar Baerlocher GM, Mak J, Tien T, Lansdorp PM. Telomere length measurement by fluorescence in situ hybridization and flow cytometry: tips and pitfalls. Cytometry. 2002;47:89–99. Article CAS Google Scholar Marsh JC. Management of acquired aplastic anaemia. Blood Rev. 2005;19:143–151. Article Google Scholar Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H, and the German Aplastic Anemia Study Group. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood. 2003;101:1236–1242. Article CAS Google Scholar Alter BP. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Look AT, Ginsburg D, eds. Nathan and Oski’s Hematology of Infancy and Childhood. 6th ed. Philadelphia, PA: WB Saunders, 2003:280–365. Google Scholar Alter BP, Gardner FH, Hall RE. Treatment of dyskeratosis congenita with granulocyte colony-stimulating factor and erythropoietin. Br J Haematol. 1997;97:309–311. Article CAS Google Scholar Gungor T, Corbacioglu S, Storb R, Seger RA. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita. Bone Marrow Transplant. 2003;31:407–410. Article CAS Google Scholar Download references MPH, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Executive Plaza South, Room 7020, 20852-7231, Rockville, MD, USA Mohamad M. Al-Rahawan, Neelam Giri & Blanche P. Alter Children’s National Medical Center, Pediatric Hematology/Oncology, Center for Cancer and Blood Disorders, The George Washington University Medical Center, Washington, DC, USA Mohamad M. Al-Rahawan You can also search for this author in PubMed Google Scholar You can also search for this author in PubMed Google Scholar You can also search for this author in PubMed Google Scholar Correspondence to Mohamad M. Al-Rahawan or Neelam Giri or Blanche P. Alter. Al-Rahawan, M.M., Giri, N. & Alter, B.P. Intensive Immunosuppression Therapy for Aplastic Anemia Associated with Dyskeratosis Congenita. Int J Hematol 83, 275–276 (2006). https://doi.org/10.1532/IJH97.06030 Download citation Received: 08 December 2005 Accepted: 06 January 2006 Published: 01 April 2006 Issue Date: April 2006 DOI: https://doi.org/10.1532/IJH97.06030